Hims & Hers vs Loop Health
Two GLP-1 desks, one scoreboard. We put Hims & Hers and Loop Health head-to-head on the published Brief Score — the same six factors, scored the same way.
Hims & Hers
FDA warning letter, September 2025 — issued to Hims & Hers Health, Inc. dba Hims. See the FDA's warning letter database.
The verdict
Hims & Hers takes this head-to-head.
Hims & Hers scores 85 to 75 on our six-factor Brief Score — Mass-market, app-first weight program with nationwide reach — watch the compounded-supply headlines.
That doesn't make Loop Health a bad call — it's best for readers who want peptide and wellness membership with glp-1s as one offering. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Hims & Hers | Loop Health | |
|---|---|---|
| Brief Score | 85/100 (B) | 75/100 (C) |
| Semaglutide | $199/mo | From $199/mo (all doses, microdose tier, membership required, compounded) |
| Tirzepatide | Not disclosed | From $299/mo (all doses, microdose tier, membership required, compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Risingprice rising | Newnew to the tracker, no prior reading |
Hims & Hers: App-first reach is nationwide, but compounded supply has drawn industry-wide scrutiny.
Loop Health: New to the tracker on 1 August 2026, and read on the provider's own site rather than taken on trust: we checked https://loop.health/ on 2026-08-01 and this row reflects what that page says. The line we publish is From $199/mo (all doses, microdose tier, membership required, compounded). There is no earlier reading of ours to compare it against yet.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.